Literature DB >> 12824530

Interaction of p53 with the adenovirus E1B-55 kDa protein.

Judith Roth1, Matthias Dobbelstein.   

Abstract

The E1B-55 kDa oncoprotein of adenovirus type 5 targets the tumor suppressor protein p53. This includes four distinct activities: (i) biochemical interaction of E1B-55 kDa with p53; (ii) inhibition of p53-induced transcription; (iii) relocalization of p53 from the nucleus to the cytoplasm; and (iv) in the simultaneous presence of E1B-55 kDa and the adenovirus E4-34 kDa (E4orf6) protein, extensive destabilization of p53. These activities can be observed experimentally, using co-immunoprecipitation of p53 with E1B-55 kDa, luciferase reporter assay of p53 activity, immunofluorescence to localize p53 and E1B-55 kDa, and immunoblot analysis of p53 levels. These experimental systems can be useful when analyzing novel interaction partners and modulators of p53, or in deciding whether adenovirus oncoproteins interact with novel growth regulatory proteins. Protocols describing the four methods are provided in this chapter.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12824530     DOI: 10.1385/1-59259-408-5:135

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  E1B-55-kilodalton protein is not required to block p53-induced transcription during adenovirus infection.

Authors:  Urs Hobom; Matthias Dobbelstein
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

2.  Enhanced cytotoxicity without internuclear spread of adenovirus upon cell fusion by measles virus glycoproteins.

Authors:  German P Horn; Sompong Vongpunsawad; Evelyn Kornmann; Barbara Fritz; Dirk P Dittmer; Roberto Cattaneo; Matthias Dobbelstein
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

3.  Heat shock protein 72 expression allows permissive replication of oncolytic adenovirus dl1520 (ONYX-015) in rat glioblastoma cells.

Authors:  Jonathan Madara; James A Krewet; Maulik Shah
Journal:  Mol Cancer       Date:  2005-03-11       Impact factor: 27.401

Review 4.  Oncogenes: The Passport for Viral Oncolysis Through PKR Inhibition.

Authors:  Janaina Fernandes
Journal:  Biomark Cancer       Date:  2016-07-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.